Podcasts about respiratory medicine

Learning Objectives:By the end of this series, listeners should be able to discuss:The physiologic rationale supporting the use of airway pressure release ventilation (APRV) in ARDS. The patient populations most likely to benefit from APRV.Key published evidence that informs our use of APRV in critical care.An expert approach to managing a patient with APRV.Next steps in research that will direct our understanding of the use of APRV in pediatric critical care.About our Guest: Dr. Palen Mallory is an assistant professor of pediatrics at Duke University and a pediatric intensivist at Duke Children's Hospital. She completed medical school at Virginia Commonwealth University, a pediatric residency at Emory University, and a critical care fellowship at Vanderbilt University. She is interested in respiratory care research, including ECMO, respiratory failure, and ARDS.Selected References:Mallory, P., & Cheifetz, I. (2020). A comprehensive review of the use and understanding of airway pressure release ventilation. Expert Review of Respiratory Medicine, 14(3), 307–315. https://doi.org/10.1080/17476348.2020.1708719Frawley, P. M., & Habashi, N. M. (2004). Airway pressure release ventilation and pediatrics: Theory and practice. Critical Care Nursing Clinics of North America, 16(3 SPEC. ISS.), 337–348. https://doi.org/10.1016/J.CCELL.2004.04.003Fredericks, A. S., Bunker, M. P., Gliga, L. A., Ebeling, C. G., Ringqvist, J. R. B., Heravi, H., Manley, J., Valladares, J., & Romito, B. T. (2020). Airway Pressure Release Ventilation: A Review of the Evidence, Theoretical Benefits, and Alternative Titration Strategies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 14. https://doi.org/10.1177/1179548420903297APRV Guideline - EMCrit Project. (n.d.). Retrieved March 30, 2025, from https://emcrit.org/squirt/aprv/Andrews P, Shiber J, Madden M, Nieman GF, Camporota L, Habashi NM. Myths and Misconceptions of Airway Pressure Release Ventilation: Getting Past the Noise and on to the Signal. Front Physiol. 2022 Jul 25;13:928562. doi: 10.3389/fphys.2022.928562. PMID: 35957Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

Learning Objectives:By the end of this series, listeners should be able to discuss:The physiologic rationale supporting the use of airway pressure release ventilation (APRV) in ARDS. The patient populations most likely to benefit from APRV.Key published evidence that informs our use of APRV in critical care.An expert approach to managing a patient with APRV.Next steps in research that will direct our understanding of the use of APRV in pediatric critical care.About our Guest: Dr. Palen Mallory is an assistant professor of pediatrics at Duke University and a pediatric intensivist at Duke Children's Hospital. She completed medical school at Virginia Commonwealth University, a pediatric residency at Emory University, and a critical care fellowship at Vanderbilt University. She is interested in respiratory care research, including ECMO, respiratory failure, and ARDS.Selected References:Mallory, P., & Cheifetz, I. (2020). A comprehensive review of the use and understanding of airway pressure release ventilation. Expert Review of Respiratory Medicine, 14(3), 307–315. https://doi.org/10.1080/17476348.2020.1708719Frawley, P. M., & Habashi, N. M. (2004). Airway pressure release ventilation and pediatrics: Theory and practice. Critical Care Nursing Clinics of North America, 16(3 SPEC. ISS.), 337–348. https://doi.org/10.1016/J.CCELL.2004.04.003Fredericks, A. S., Bunker, M. P., Gliga, L. A., Ebeling, C. G., Ringqvist, J. R. B., Heravi, H., Manley, J., Valladares, J., & Romito, B. T. (2020). Airway Pressure Release Ventilation: A Review of the Evidence, Theoretical Benefits, and Alternative Titration Strategies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 14. https://doi.org/10.1177/1179548420903297APRV Guideline - EMCrit Project. (n.d.). Retrieved March 30, 2025, from https://emcrit.org/squirt/aprv/Andrews P, Shiber J, Madden M, Nieman GF, Camporota L, Habashi NM. Myths and Misconceptions of Airway Pressure Release Ventilation: Getting Past the Noise and on to the Signal. Front Physiol. 2022 Jul 25;13:928562. doi: 10.3389/fphys.2022.928562. PMID: 35957Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

Listen in as Cristina Mussini, MD; Martin Witzenrath, MD, FERS; and Michele Bartoletti, MD, PhD, discuss treatment strategies for people who are immunocompromised with COVID-19 in the hospital setting, including: Antiviral therapy with remdesivirDexamethasone for patients with hematologic malignanciesConsiderations regarding other immunomodulators such as JAK inhibitors or IL-6 inhibitorsA detailed patient case to illustrate key takeaways Presenters:Michele Bartoletti, MD, PhD​Associate Professor of Infectious DiseasesDepartment of Biomedical SciencesHumanitas UniversityPieve Emanuele (MI), ItalyHead of Infectious Diseases UnitIRCCS Humanitas Research HospitalRozzano (MI), ItalyCristina Mussini, MD​Full Professor of Infectious DiseasesChief of the Department of Infectious DiseasesUniversity of Modena and Reggio EmiliaModena, ItalyMartin Witzenrath, MD, FERS Medical DirectorCharite Centrum 12Internal Medicine & DermatologyProfessor and Chair for Respiratory Medicine and Critical CareDepartment of Infectious Disease, Respiratory Medicine and Critical CareCharite Campus Mitte/Campus Virchow Klinikum/Campus Benamin FranklinCharite – University of BerlinBerlin, GermanyLink to full program:https://bit.ly/4fs7HcbDownloadable slides:https://bit.ly/3XP1fpJGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss the management of mild to moderate COVID-19 in patients who are immunocompromised, including:Initial workup, which may include laboratory tests and/or imagingLatest data on the use of remdesivir or nirmatrelvir plus ritonavir for mild to moderate COVID-19, including considerations for drug–drug interactions Presenters:Martin Witzenrath, MD, FERSMedical DirectorCharite Centrum 12Internal Medicine & DermatologyProfessor and Chair for Respiratory Medicine and Critical CareDepartment of Infectious Disease, Respiratory Medicine and Critical CareCharite Campus Mitte/Campus Virchow Klinikum/Campus Benjamin FranklinCharite – University of BerlinBerlin, GermanyMichele Bartoletti, MD, PhDAssociate Professor of Infectious DiseasesDepartment of Biomedical SciencesHumanitas UniversityPieve Emanuele (MI), ItalyHead of Infectious Diseases UnitIRCCS Humanitas Research HospitalRozzano (MI), Italy Link to full program: https://bit.ly/4gu2gcUDownloadable slides: https://bit.ly/3CGlDBSGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Cristina Mussini, MD, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss:Current SARS-CoV-2 trends in the EURisk factors for severe COVID-19 outcomes, including the spectrum of risk based on immune system statusFactors that may affect vaccine efficacy in chronic lymphocytic leukemia and other lymphoid malignanciesConsiderations for determining people at high risk for COVID-19 progression Presenters:Cristina Mussini, MDFull Professor of Infectious DiseasesDivision of Infectious DiseasesUniversity of Modena and Reggio EmiliaModena, ItalyMartin Witzenrath, MD, FERSMedical DirectorCharite Centrum 12Internal Medicine & DermatologyProfessor and Chair for Respiratory Medicine and Critical CareDepartment of Infectious Disease, Respiratory Medicine and Critical CareCharite Campus Mitte/Campus Virchow Klinikum/Campus Benjamin FranklinCharite – University of BerlinBerlin, GermanyMichele Bartoletti, MD, PhDAssociate Professor of Infectious DiseasesDepartment of Biomedical SciencesHumanitas UniversityPieve Emanuele (MI), ItalyHead of Infectious Diseases UnitIRCCS Humanitas Research HospitalRozzano (MI), ItalyLink to full program: https://bit.ly/4gu2gcUDownloadable slides: https://bit.ly/42IlpELGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Human Metapneumovirus (HMPV), a respiratory virus capable of infecting people of all ages, spreads through direct human contact or contaminated surfaces. It often causes mild upper respiratory tract infections, similar to COVID-19. Recently, HMPV has been reported to be spreading in countries like China and India. But what are experts saying about this? Should the public be genuinely concerned? In this podcast episode, SBS Hindi speaks with Professor Sarath Ranganathan, a Melbourne-based expert in respiratory medicine, to discuss the virus.

As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Marianne Baastrup Soendergaard (Department of Respiratory Medicine, Copenhagen University Hospital – Bispebjerg, Copenhagen, Denmark) about the OPTIMAL study: an open-label randomised controlled trial of titration of anti-interleukin-5 biologic therapy in severe asthma.

In this episode of Run with Fitpage, we have Dr Nick Tiller with us. Dr Nick discusses all about nasal and mouth breathing, and the pseudoscience around the topic, with our host Vikas Singh. Dr. Nick Tiller is a Research Associate at the Lundquist Institute, Harbor-UCLA Medical Center, and the acclaimed author of "The Skeptic's Guide to Sports Science," recognized as one of Book Authority's "Best Sports Science Books of All Time." With a strong background in exercise physiology and respiratory medicine, Dr. Tiller has made significant contributions to sports science, particularly in the fields of exercise physiology and respiratory research.Dr. Tiller began his career working with elite athletes and coaches at the Olympic Center in the UK. He earned his PhD in Applied Physiology (Respiratory) from Brunel University London, followed by academic positions as an Assistant and Associate Professor in the North of England. In 2019, he relocated to Los Angeles to continue his groundbreaking research at the renowned Lundquist Institute. In addition to his research, Dr. Tiller is a columnist for Skeptical Inquirer and Ultra-Running Magazine, and an Associate Editor at the International Journal of Sports Nutrition. His dedication to science communication and critical thinking has earned him the title of Fellow at the Committee for Skeptical Inquiry.Review article mentioned in the podcast: Distinguishing science from pseudoscience in commercial respiratory interventions: an evidence-based guide for health and exercise professionalFollow Dr Nick Tiller's work on,Website: www.nbtiller.comInstagram: @nb.tillerTwitter: @NBTillerAbout Vikas Singh:Vikas Singh, an MBA from Chicago Booth, worked at Goldman Sachs, Morgan Stanley, APGlobale, and Reliance before coming up with the idea of democratizing fitness knowledge and helping beginners get on a fitness journey. Vikas is an avid long-distance runner, building fitpage to help people learn, train, and move better.For more information on Vikas, or to leave any feedback and requests, you can reach out to him via the channels below:Instagram: @vikas_singhhLinkedIn: Vikas SinghTwitter: @vikashsingh101Subscribe To Our Newsletter For Weekly Nuggets of Knowledge!

Lung cancer is Australia's deadliest cancer. When patients develop symptoms like coughing it is generally no longer curable by surgery or other treatments.The National Lung Cancer Screening Program will begin next year and will involve routine scanning in the hope of catching the disease in its earliest stages. More information, including who's eligible for the Program, is available hereThis podcast is brought to you by Macquarie University Hospital, a part of MQ Health.Professor of Respiratory Medicine at Macquarie University Hospital, Alvin Ing told the MJA the screening program could push the cure rate for lung cancer to as high as 90%,

Pat was joined by Professor Marcus Butler, Consultant in Respiratory Medicine and Medical Director of the Asthma Society of Ireland, to discuss the impact of seasonal allergies on asthma. They answered listener questions and provided tips on managing asthma effectively during allergy season.

May 6th to 10th marks asthma awareness week in Ireland which aims to spread awareness of the respiratory condition and its preventative measures. Pat was joined on the show by Prof Marcus Butler, Consultant in Respiratory Medicine at St Vincent's Hospital and also by Edel Abberton who is living with asthma.

Listen to this podcast featuring Dr Bornali Datta, Director, Respiratory Medicine at Medanta, and Project Lead of Mission TB Free Haryana. She shares insights of the incredible and high-impact journey of Medanta vans since 2015 onwards of how they are reaching the unreached with WHO recommended and quality assured TB diagnostics and services in Haryana, Delhi, and other parts of India. She is in conversation with Shobha Shukla, CNS founder Managing Editor and Chairperson of Global Antimicrobial Resistance Media Alliance.Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, TuneIn, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, iVoox, and other podcast streaming platforms.ThanksCNS team#EndTBDialogues #TB #FindallTB #treatallTB #preventallTB #diagnosis #detectTB #findTB #treatTB #preventTB #drugresistance #YesWeCanEndTB #TBMukt #TBMuktBharat #TBFreeWorld #TBFreeIndia #DiagnosticDelay #CatastrophicCost #TBMuktHaryana #TBFreeHaryana #Medanta #LabonWheels #MissionTBFreeHaryana #BornaliDatta #Conversation #Dialogue

Vaping. E-cigarettes. Heat sticks. They're super popular (especially among young people)- an estimated 22 MILLION e-cigarettes are sold in the US every MONTH. As we have (thankfully) seen traditional combustible tobacco cigarette smoking decline over the past couple decades, the flip side is an astronomical increase in vaping. Many e-cigarette brands market themselves as a safer, healthier alternative to smoking cigarettes, calling their vape products "ENDS" or "electronic nicotine delivery systems". Is this reality? Is vaping less harmful to you than smoking? Your Doctor Friends want to clear the air, make the conversation about vaping a little less foggy. Today we will answer questions like: How does vaping affect our health directly? What does the research show about the risks of vaping with respect to cardiovascular problems, cancer, or lung disease? What the heck is "popcorn lung"? What about VAPI (vaping associated pulmonary injury)? What does nicotine alone do to our bodies? How much nicotine is in a vape? A cigarette? What's actually in vape aerosol/mist? How is it different than cigarette smoke? Is it bad for me? Is vaping instead of smoking actually good "harm reduction"? How are e-cigarettes marketed specifically to kids and young adults? Why? What should we do about it? Let's all inform ourselves about the issues surrounding vaping/e-cigarettes, so we can all breathe easier! Resources for today's episode include: A 2022 Tobacco Use Insights journal review of literature on e-cigarette harm vs harm reduction. A March 11, 2024 study and discussion in Pediatrics journal about disposable e-cigarettes, use patterns in youth, and how to counteract the tobacco industry's "reduced-harm" marketing tropes. An August 2023 JAMA article about youth flavored e-cigarette use before and after partial flavoring bans. A Guardian article about the amount of nicotine in vapes vs cigarettes. A 2023 article in Advances in Respiratory Medicine outlining the data on vaping and cancer risk. Results from the 2023 FDA Annual National Youth Tobacco Survey. A 2016 study in Environmental Health Perspectives about acrolein, diacetyl, and other chemicals found in flavored e-cigarettes. A 2019 Cureus article about vitamin E acetate as plausible cause of acute vaping-related lung illness. A 1/24/24 CNN article about the lack of progress on the US menthol cigarette ban. Wikipedia article on "bronchiolitis obliterans". A December 2023 WHO news release about the urgent need to protect children and prevent uptake of e-cigarettes. A 2023 Cureus meta-analysis on risks of vaping on cardiovascular disease. An October 2023 Pediatrics journal article outlining vaping cessation methods used by US adolescent e-cigarette users. Thanks for tuning in, folks! Please sign up for our "PULSE CHECK" monthly newsletter! Signup is easy, right on our website page, and we PROMISE we will not spam you! We just want to send you cool articles, videos and thoughts :) For more episodes, limited edition merch, or to become a Friend of Your Doctor Friends (and more), follow this link!   Find us at: Website: yourdoctorfriendspodcast.com  Email: yourdoctorfriendspodcast@gmail.com  Connect with us: @your_doctor_friends (IG) Send/DM us a voice memo/question and we might play it on the show! @yourdoctorfriendspodcast1013 (YouTube) @JeremyAllandMD (IG, FB, Twitter) @JuliaBrueneMD (IG) @HealthPodNet (IG)

“He stated that the United States was in possession of a craft of unknown origin and had successfully gained access to its interior. This craft had a streamlined configuration suitable for aerodynamic flight but no intakes, exhaust, wings, or control surfaces. In fact, it appeared not to have an engine, fuel tanks, or fuel.” Quote from ‘Inside the US Government Covert UFO Program: Initial Revelations' Colm A. Kelleher, Ph.D., is a biochemist with a fifteen-year research career in cell and molecular biology. Following his Ph.D. in biochemistry from the University of Dublin, Trinity College in 1983, Kelleher worked at the Ontario Cancer Institute, the Terry Fox Cancer Research Laboratory, and the National Jewish Center for Immunology and Respiratory Medicine. For the past eight years he has worked as project manager and team leader at a private research institute, using forensic science methodology to unravel scientific anomalies. Inside the US Government Covert UFO Program: Initial Revelations https://a.co/d/1QI3rnV

Public Service Announcement: Would you like to support us ? We are raising money for our NFP and podcast to obtain an office space and podcast recording studio for 2024. Our goal is $10, 000 AUD and any donation big or small is helpful ! If you're interested in supporting us, please email us at hello@pbbmedia.org for more information. If you're not familiar, Check out our work at pbbmedia.org In this interview, Oni Blecher interviews Dr. Howard Chilton has been a neonatologist (a baby's physician) for over 45 years. He was born in York, England and studied at St Mary's Hospital Medical School in London. After wonderful years in London in the swinging sixties he graduated then interned at Addington Hospital on the beach in Durban, South Africa. Following this, he was accepted for a Senior House Physician appointment in Neonatal Medicine at Harari Hospital in then, Salisbury Rhodesia, now, Harare, Zimbabwe). After more training, Howard eventually obtained paediatric appointments at the Hammersmith Hospital and the Westminster Children's Hospital, then, after obtaining his MRCP (UK) degree, the John Radcliffe Hospital, Oxford where he also did a short fellowship. He then became a SHO at the Hospital for Sick Children, Great Ormond Street, London in the Department of Respiratory Medicine. He did a mandatory Neonatal Fellowship in the US at Denver Children's Hospital which included two years in a centre of excellence in high tech neonatology including doing neonatal ground and air retrievals, really taught him how to look after the sickest, smallest babies.Before starting this fellowship though, he had a long stopover in Sydney doing locum Respiratory and Paediatric jobs, to check out job prospects. During one job at Prince Henry Hospital he met a beautiful nursing sister called Tamara.At the end of the fellowship, Howard was appointed as the Director of Newborn Services at the Royal Hospital for Women in Sydney, where he held this position for over twenty years, resigning in 1999 to concentrate on clinical work and parent education. Apart from looking after babies and their parents, Howard now spends a lot of his time talking: to parent groups, or to conferences in Australia and overseas, and to media outlets about ‘responsive parenting' and the myriad issues which arise for parents when they take their new baby home. He believes knowledge of the biology of the baby can help parents understand and meet their baby's needs and enables them to relax and enjoy the wonderful experience of parenting.He married Tamara soon after arriving back in Sydney from the USA and she remains the light of his life. They have two daughters, Georgina and Isabella and five grandchildren ! all under 5 years of age. Find out more about Dr. Chilton, including his well renowned books at babydoc.com.au

Blood gases are really commonly used in ED, Critical Care, Respiratory Medicine and Prehospitally. In fact, you'd do well to walk 10 meters in an ED without being given one to sign off! But it's for good reason, because they give you additional information about what's going on from a respiratory and metabolic perspective in the patient. And it's probably worth mentioning at this point, this episode is going to be pretty ‘science-heavy', there should be something in here for everyone; from the clinician that's been looking at these things for the last 30 years, to those that haven't started interpreting gases. So arterial blood gases can tell you about the efficacy of the patients ventilation in terms of their partial pressures of oxygen and carbon dioxide levels and also from a metabolic perspective about other disorders of their acid-base balance.  In the episode we'll be covering the following; -Overview of blood gases -Respiratory & metabolic sides of the gas -Acidaemia -Alkalaemia -Bicarbonate or base excess? -Compensation -Oxygenation -Anion gaps -System of interpretation -Venous gases -Clinical application & examples of interpretation We'll be referring to the equation listed on our webpage, so make sure you go and have a look at that and all the references listed. Once you've listened to the podcast make sure you run through the quiz below to consolidate the concepts covered with some more gas examples and of course get you free CPD certificate for your TheResusRoom portfolio! Once again we'd love to hear any comments or questions either via the website or social media. Enjoy! Simon, Rob & James

Muiris FitzGerald is Emeritus Professor of Medicine and Therapeutics at UCD and was Professor of Medicine and Consultant Physician at SVUH (St Vincent's University Hospital) from 1977 to 2006. Muiris is a former two-term Chairman of the HRB (Health Research Board) and served on the Foundation Board of HIQA (Health Information and Quality Authority), the ISCP (Irish Society of Chartered Physiotherapists), the NMBI (Nursing and Midwifery Board of Ireland – formerly An Bord Altranais) and Comhairle na nOispideal for four terms. Muiris was the recipient of the inaugural ITS (Irish Thoracic Society) Award for Outstanding Contribution to Respiratory Medicine in 2009, which proved an excellent opportunity to celebrate and recognise the Professor's distinguished career and his unique and invaluable contribution to the field of respiratory medicine. After his Internship, Muiris trained at the Seton Hall Medical School Jersey City, New Jersey, US, the University of Birmingham and as an International Fogarty – NIH Fellow at Boston University Medical School Thoracic Services under the aegis of Ed Gaensler, Gordon Snider and Charles Carrington. On returning home in 1977, to take up his appointment as Consultant Physician at SVUH, Muiris established the hospital's first Pulmonary Function Laboratory and initiated the first Adult and Adolescent CF (Cystic Fibrosis) Service in Ireland, in addition to a suite of specialist outpatient clinics for patients with sarcoidosis, lung fibrosis/rare lung diseases and asthma. Muiris FitzGerald was born in Dublin in 1941 and graduated from UCD School of Medicine. He did postgraduate training in UCD, Seton Hall University New Jersey, US, University of Birmingham, UK and Boston University School of Medicine, US.  --- Send in a voice message: https://podcasters.spotify.com/pod/show/portraitsofclongowes/message

'…So take a good look in the mirror and tell me who you see, the one who Jesus died for or the one you'd rather be? Can you find it in your heart to show mercy to the one the Father loved so much that he gave his only son?' – lyrics from ‘The Golden Boy and The Prodigal' by Jason Gray.As humans, at times failure is inevitable, but as doctors, the possible consequences of our failure can be fatal.  We look to combine Biblical principles with practical recommendations as we explore what it means to be successful. We also look at different kinds of failure that we encounter, and discuss possible ways to respond.    This is a stand-alone episode of the Junior Doctor Foundations podcast. Your host is Lizzy Kennedy (a junior doctor based in Devon); she is joined by guest Tim Hinks (Associate Professor of Respiratory Medicine) and Felicia Wong (GP and CMF Head of Doctors' Ministries).  Support the show

On World Asthma Day, we ask Should asthma medication be free for all? To discuss further Pat spoke to Professor Marcus Butler, Consultant in Respiratory Medicine at St Vincent's Hospital and also Eilis Ni Chaithnia, CEO of the Asthma Society.

Dr John Blakey, Respiratory Physician, Department of Respiratory Medicine, Sir Charles Gairdner Hospital and Ms Brooke Kyle, Clinical Nurse Consultant, Sir Charles Gairdner Hospital join Paula Voce to discuss all things asthma.Throughout the podcast, Dr Blakely and Ms Kyle discuss some of the ways people can manage their asthma, as well as some of the growing research initiatives within WA.

Noninvasive respiratory support is an important modality utilized in the pediatric critical care setting to treat respiratory failure without the use of an artificial airway. On today's discussion, pediatric critical care fellow, Dr. John-David Bruce joins pediatric hospitalist, Dr. Brynn Ehlers and Dr. Gene Fisher who is a pediatric intensivist that serves as the division chief of Pediatric Critical Care unit at the Children's Hospital of Georgia. After listening to this podcast, learners should be able to:  1. Recognize different types of noninvasive respiratory support 2. Have an understanding of basic settings involved in the different modes of noninvasive respiratory support 3. Discuss conditions that are most ideal for noninvasive respiratory support  4. Recognize when it is necessary to escalate to a higher mode of respiratory support 5. Common complications of noninvasive respiratory support and how do you treat them. FREE CME Credit (requires free sign-up):  https://mcg.cloud-cme.com/course/courseoverview?P=0&EID=19507  References: Amin, R, & Arca, MJ. Feasibility of non-invasive neurally adjusted ventilator assist after congenital diaphragmatic hernia repair. Journal of Pediatric Surgery, 2019;54(3):434-438. Coletti, KD, Bagdure, DN, Walker, LK, Remy, KE, & Custer, JW. High-flow nasal cannula utilization in pediatric critical care. Respiratory Care, 2017;62(8):1023-1029. Desai, JP, & Moustarah, F. Pulmonary Compliance. StatPearls Publishing. 2021.  https://www.ncbi.nlm.nih.gov/books/NBK538324/ Fedor, KL. Noninvasive respiratory support in infants and children. Respiratory Care, 2017;62(6):699-717. Franklin, D, Babl, FE, & Schlapbach, LJ, et al. A randomized trial of high-flow oxygen therapy in infants with bronchiolitis. The New England Journal of Medicine, 2018;378:1121-1131. Intagliata, S, Rizzo, A, & Gossman, WG. Physiology, Lung Dead Space. StatPearls Publishing. 2020. https://www.ncbi.nlm.nih.gov/books/NBK482501/ Morrison, WE, Nelson McMillan, KL, & Shaffner, DH. (Eds.). Roger's Handbook of Pediatric Intensive Care (5th ed.). 2017. Wolters Kluwer. Najaf-Zadeh A, & Leclerc F. Noninvasive positive pressure ventilation for acute respiratory failure in children: a concise review. Ann Intensive Care. 2011;1(1):15. doi:10.1186/2110-5820-1-15 Oymar, K, & Bardsen, K. Continuous positive airway pressure for bronchiolitis in a general paediatric ward; a feasibility study. BMC Pediatrics. 2014;14:122. Pope, JF, & Birnkrant, DJ. Noninvasive ventilation to facilitate extubation in a pediatric intensive care unit. Journal of Intensive Care Medicine. 2000;15(2):99-103.  Storre, JH, Bohm, P, Dreher, M, & Windisch, W. Clinical impact of leak compensation during non-invasive ventilation. Respiratory Medicine. 2009;103(10):1477-1483.  Silver AH, Nazif JM. Bronchiolitis. Pediatr Rev. 2019;40(11):568-576. doi:10.1542/pir.2018-0260

Despite all the advances developed in critical illness, survivors of the ICU have a long journey to healing and recovery. In this episode of the podcast, we will discuss outcomes after critical illness. Our guest is Dr. Margaret Herridge, Professor of Medicine, Senior Scientist in Critical Care and Respiratory Medicine at the University of Toronto. Dr. Herridge is also Director of Critical Care Research. Director of the RECOVER Program, and Clinical Director of the Grace RECOVER Program for Chronic Critical Illness, in the University Health Network, Toronto, Canada. Additional Resources: Outcomes after Critical Illness. M. Herridge and E. Azoulay: https://pubmed.ncbi.nlm.nih.gov/36884324/ Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Hopkins RO, et al: https://pubmed.ncbi.nlm.nih.gov/10390379/ One-year outcomes in survivors of the acute respiratory distress syndrome. Herridge m, et al: https://pubmed.ncbi.nlm.nih.gov/12594312/ Long-term cognitive impairment after critical illness. Pandharipande PP, et al: https://pubmed.ncbi.nlm.nih.gov/24088092/ The RECOVER Program: disability risk groups and 1-year outcome after 7 or more days of mechanical ventilation. Herridge M, et al: https://pubmed.ncbi.nlm.nih.gov/26974173/ Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study. Gayat E, et al: https://pubmed.ncbi.nlm.nih.gov/29347987/ Symptoms of anxiety and depression in family members of intensive care unit patients. Pochard F, et al: https://pubmed.ncbi.nlm.nih.gov/11588447/ Books Mentioned in this Episode: Bel Canto. By Ann Patchett: bit.ly/3nWs7Vp Commonwealth. By Ann Patchett: bit.ly/43pWSCt

Chronic lung disease currently accounts for a large percentage of deaths in both males and females. This podcast challenges stereotypes and provides insights into the differences in respiratory care between sexes. Featured on this episode is Nicolas Roche, Professor of Respiratory Medicine, Paris Cité University, and the Department of Respiratory Medicine, Cochin Hospital, Paris, France. Roche gives an overview on chronic obstructive pulmonary disease (COPD), describing the leading causes and burden of this condition, and addressing gender differences and the perception that this is a predominantly male disease. Physical, social, and lifestyle differences are all considered in relation to common lung diseases such as asthma and bronchiectasis. Roche also uses his expertise to outline several important clinical considerations, including initiatives to combat underdiagnosis of COPD in females, and the steps that can be taken to improve disparities in respiratory care based on sex and gender. This content is sponsored by Philips.

In part two of our Respiratory special we sat down with Ren Lawlor, a nurse practitioner who specialises in Respiratory Medicine. We discussed her career, moving from secondary care to primary care, and what her current clinical and educational work entails. We also unpicked the presentation of COPD and how to distinguish existing symptoms from something more sinister. As an interesting follow on from our last episode, she also shared her perspective on inhalers and the shift in guidelines towards combined therapy. This episode is a really interesting listen for anyone interested in respiratory medicine or a specialist career within nursing. 

Host: Marius M. Hoeper, MD A recent study explored the safety and efficacy of sotatercept on top of background pulmonary arterial hypertension (PAH) therapy. To learn more about this clinical data, Dr. Marius M. Hoeper, a Professor of Medicine and the Deputy Director of the Department of Respiratory Medicine at Hannover Medical School in Hannover, Germany, dives into the results of this trial and explores how they may impact patients with PAH.

Colm A. Kelleher, Ph.D., is a biochemist with a fifteen-year research career in cell and molecular biology. Following his Ph.D. in biochemistry from the University of Dublin, Trinity College in 1983, Kelleher worked at the Ontario Cancer Institute, the Terry Fox Cancer Research Laboratory, and the National Jewish Center for Immunology and Respiratory Medicine. He more recently has worked as project manager and team leader at a private research institute (NIDS), using forensic science methodology to unravel scientific anomalies, including animal mutilation cases, investigations of black triangle incidents, and other unexplained phenomena. He was a program manager for the largest government-funded UFO investigation (AAWSAP) overseen by the Defense Intelligence Agency and is currently senior manager with BICS, the Bigelow Institute for Consciousness Studies.  GOT A TIP? Reach out to us at WeaponizedPodcast@Proton.me For breaking news, follow Corbell & Knapp on all social media. Extras and bonuses from the episode can be found at weaponizedpodcast.com To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Emma Grainger, Editor-in-Chief of The Lancet Respiratory Medicine, discusses the January issue and plans to celebrate the 10-year anniversary of the journal. Read the Editorial from the 10th anniversary issue:Past learnings and new beginnings in the digital age

In this week's episode, we are talking to the Tupumue Project, who applied creative participatory methods alongside clinical data to understand how many children, in two communities in Nairobi, Kenya have lung problems, and to explore children's experiences of lung problems and air pollution. The project used a variety of creative research methods including drawings, drama, walking interviews with go pros, comics, graffiti and others. They even engaged children in co- analysis and theme development. Co-host for this episode, Dr. Hellen Meme, told us more about the programme; “The choice of the word “Tupumue” (meaning “lets breathe”!) as an identity of the program was because breathing is a function important to all. The Tupumue programme was a complex undertaking considering the broadness of the subject that was covered, in regard to establishing the burden of non-communicable lung diseases in school children and risk factors in both an informal and formal community context. The necessary skill pool had to be wide to achieve this and hence the broad collaboration involving a multidisciplinary team derived from several North and South institutions. For everyone to own the study, we held consultative meetings through which we established a niche for everyone to participate. We are in the process of widely disseminating our study findings and are currently sharing our results with all stakeholders including participating schools and the community in order to get their views on the findings before we engage policy makers”. This episode features: Dr. Hellen Meme (co-host) - Chief Research Scientist, Kenya Medical Research Institute (KEMRI) Hellen Meme's research work spans over 30 years and involves health and communities. Her research area of interest is in respiratory diseases with bias towards conducting research in congregate communities. This necessitates a broad skill base as well as innovation in planning approaches appropriate for project implementation. In this regard, engagement of community and other stakeholders is key. Dr Sarah West - Centre Director and Senior Research Fellow, Stockholm Environment Institute, University of York Sarah has been using citizen science approaches since she began work at SEI York in 2008, working on topics ranging from air pollution and biodiversity through to parenting and food waste. All her work uses citizen science approaches to engage a diverse range of people with research. She uses this approach because she believes that well designed projects can have huge benefits for advancing research and for making a difference for all those involved in projects. She also conducts research around the method of citizen science, looking at who is and isn't participating in projects, and evaluating projects' efficacy. Relevant links: https://www.sei.org/featured/citizen-science-month/ Fred Orina - Senior Research Scientist, Kenya Medical Research Institute (KEMRI) Fred's interest is research implementation. He has 10 years' experience in coordinating the implementation of human health research, with a focus on lung health studies in both static and nomadic communities. This involves liaising with communities and diverse stakeholders. With a scientific background, he acts as the interlink between the community, researchers, and the sponsor. Professor Graham Devereux - Professor of Respiratory Medicine, Liverpool School of Tropical Medicine Graham is a Professor of Respiratory Medicine with research interests in the antenatal influences on the life course of airways disease and clinical trials in COPD. He...

Ben is in esteemed company on the podcast this week, joined by Dr Martin Allen (Consultant Physician and a Clinical Lead in Respiratory Medicine at University Hospital North Midlands), Kerry Mills (Advanced Respiratory Nurse Practitioner and Clinical Lead at Hereford Medical Group) and Andrea McConkey of the Wessex Academic Health Science Network, who brief us on all aspects of FeNO testing. Measuring fractional exhaled nitric oxide in the breath of patients, FeNO testing devices are a novel medical technology used to support the diagnosis of asthma. In this episode, we learn about how FeNO testing works in practice, the impact testing is having on the management and treatment of asthma and how others can get their hands on the devices and all available resources. Martin, Kerry and Andrea also welcome listeners to join a recently launched learning collaborative and share some incredibly useful links to further information on the FeNO revolution. Introduction (0.54) What is FeNO testing? (2.08) What difference has it made to the management of asthma? (5.48) Why are we not seeing a bigger uptake? (8.34) The AHSN Programme (9.32) The rollout of FeNO (12.18) FeNO equipment costing (16.15) Overcoming the barriers of Feno - Martin & Andrea (17.14) Advice about getting started (20.23) Final words (22.18)   West Midlands Academic Health Science Network's website is here. A wealth of information about FeNO is also available within the Wessex AHSN website here. The AHSN Network can support you in finding out how and where to get started on your FeNO journey here. For infographics and guidance about how the devices themselves and how testing works in practice check out the Circassia device and the Bedfont device If you're interested in finding out more about each of available devices, contact Steven who can guide you on the Circassia option, or Marc for the Bedfont device. Information about the Rapid Uptake Programme is here. NICE guidance is accessible here. For all enquiries about the Ockham podcast, please contact Ben Gowland here. To find out more information about Livi, their services and how to get in touch, check out their website here.

I was fortunate to speak with Dr. Gillian Goobie of the Center for Heart Lung Innovation at St Paul's Hospital in Vancouver as well as the Division of Respiratory Medicine at the University of British Columbia. She is the lead author on a groundbreaking paper exploring the risk of death from exposure to air pollution as well as the source of the pollution, and how it changes the risk to those breathing it. We talk about everything from the different pollution sources in more industrially exposed areas to pollution sources in areas affected by wildfire, what to do with the knowledge of this risk, how it can affect those who are most vulnerable with lung scarring or pulmonary fibrosis, and more! She also shares her gratitude for the people who participate in this trial and so many others. They help us understand more about the world around https://airhealthourhealth.org/whats-burning-pollution-sources-and-lung-scarring-with-dr-gillian-goobie/us! So what can you do? 1- Download the AirNow.gov app and become familiar with it. 2- To learn more about PM2.5 standards and history, listen to the “What's in a Standard” episode with Dan Costa from Season Two. 3- For more on how to use the Air Quality Index, listen to the “What's in an Index” episode with Dr. Franziska Rosser from last season. 4- For those in the West, particularly affected by PM2.5 and wildfire smoke, listen to the “Our Health in Wildfire Season” episode from Season Two and the “Air Inside when the smoke is outside” episode with Prof Elliot Gall from Season One. 5- Finally, consider a donation to the American Thoracic Society, whose scientific membership includes clinician-scientists like Dr. Goobie who do such important research and work hard to highlight the importance of clean air. ----------------------------------------------------------------------------------------- Visit blog post for more information, or go to airhealthourhealth.org. Follow and comment on Facebook page and Instagram. Record a question or comment on the Anchor podcast site or send an e-mail via the website. --- Send in a voice message: https://anchor.fm/airhealthourhealth/message

Development of The Greenest Inhaler podcast was supported and reviewed by Trudell Medical International. This EMJ podcast explores the carbon footprint of different inhaler devices and features the expert insight of guest speakers Omar S. Usmani, Professor of Respiratory Medicine, Imperial College London, UK, and Consultant Physician, Royal Brompton Hospital and St Mary's Hospital, London, UK; and John N. Pritchard, Private Consultant and Member of United Nations (UN) Committee on Propellant Medical Usage.

This month—two studies on COVID-19! Daniel R. Goldstein, MD, Editor-in-Chief of JHLT, is taking a short break, so the episode is hosted by Digital Media Editor Erika Lease, MD. Both COVID-19 studies come from the September issue of The Journal of Heart and Lung Transplantation, and in the episode, you'll learn more about each study and their authors.   First, the editors speak with Yael Peled, MD, Medical Director of the Heart Transplant Service at the Sheba Medical Center in Ramat Gan, Israel. She's the first author on a paper entitled “Fourth BNT162b2 vaccination neutralization of omicron infection after heart transplantation.” Dr. Lease and Marty Tam, MD, interview Dr. Peled about the study, which examples how IgG and neutralizing antibodies responded to a fourth BNT162b2 dose in heart transplant recipients against the omicron and delta variants versus the wild-type virus.   Next, we hear from C.T. Gan, MD, PhD, Consultant in Respiratory Medicine and Lung Transplantation at University Medical Center Groningen, on his study, “The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: a multicenter experience.” Dr. Lease and Van-Khue Ton, MD, discuss the study with Dr. Gan, including questions on management strategies for COVID-19 in lung transplant patients, lung function improvements after COVID-19 recovery, and potential follow up studies.   Follow along in the September issue at www.jhltonline.org/current, or, if you're an ISHLT member, log in at ishlt.org/journal-of-heart-lung-transplantation.  Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.   This episode of JHLT: The Podcast, but not the studies within, is sponsored by Bayer Pharmaceuticals.

Dr Des Cox, Royal College of Physicians in Ireland Policy Group on Tobacco and Consultant in Respiratory Medicine at Children's Health Ireland in Crumlin; and Dr. Garrett McGovern, GP specialising in Addiction Medicine & Medical Director at the Priority Medical Clinic in Dundrum

Dr Des Cox, Royal College of Physicians in Ireland Policy Group on Tobacco and Consultant in Respiratory Medicine at Children's Health Ireland in Crumlin; and Dr. Garrett McGovern, GP specialising in Addiction Medicine & Medical Director at the Priority Medical Clinic in Dundrum

Professor Seamus Linnane, Consultant in Respiratory Medicine, on the latest surge in Covid-19 cases.

Jillian McNulty, CF Patient and Campaigner, Dr Paul McNally Consultant in Respiratory Medicine with Children's Health Ireland and associate professor of Pediatrics with the RCSI

This episode covers respiratory support.Written notes can be found at https://zerotofinals.com/surgery/anaesthetics/respiratorysupport/ or in the anaesthetics and ICU section of the Zero to Finals surgery book.The audio in the episode was expertly edited by Harry Watchman.

This episode covers arterial blood gases.Written notes can be found at https://zerotofinals.com/surgery/anaesthetics/arterialbloodgases/ or in the anaesthetics and ICU section of the Zero to Finals surgery book.The audio in the episode was expertly edited by Harry Watchman.

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recently completed European Lung Cancer Congress. His guests include Dr. Lizza Hendriks, assistant professor at Maastricht University in the Netherlands. Dr. Hendriks is also a pulmonologist specializing in thoracic oncology and the program leader of the Innovative Cancer Diagnostics Therapy group at GROW School of Oncology. Joining Dr. Hendriks is Dr. Nicolas Girarda, professor of Respiratory Medicine at the Versailles Saint Quentin University and head of the Curie-Montsouris Thorax Institute in Paris.

Sam chats with Mona Bafadhel, the new Chair of Respiratory Medicine, King's College London about her career, failing and being called "challenging.”  

In this Healthed lecture, Respiratory and Sleep Physician; Dept of Respiratory  Medicine, Austin Hospital, Melbourne, A/Prof Christopher Worsnop presents a comprehensive framework for health professionals assessing COPD patients and outlines an evidence-based approach to management that includes how to decide whether inhaled corticosteroids are appropriate and how, when and for how long they should be used. See omnystudio.com/listener for privacy information.

Guest: Nicolas Girard, MD Guest: Alex Spira, MD, PhD, FACP While the management and treatment of HER2-mutated non-small cell lung cancer continues to evolve, patients still face many unmet needs. Dr. Nicolas Girard, a pneumologist and Professor of Respiratory Medicine at Versailles Saint Quentin University, explores these unmet needs and how we can solve them.

In this episode, we're joined by PA Daniel Woosey - who is the Lead Physician Associate at Surrey and Sussex Healthcare NHS Trust and has many years experience as a PA in respiratory medicine. Dan shares his thoughts on how PAs get a good start in respiratory medicine, and how his career has developed into leading the profession in his hospital trust.You can find Dan on Twitter @wooze6 You can connect with the Physician Associate PodcastTwitter - @PApodcastUKFacebook - @PApodcastUKInstagram - @PApodcastUK

The number of COVID patients needing an ICU bed in New South Wales is expected to keep climbing into October.  The problem is that even now, with demand sitting well below the state's technical ICU capacity, hospitals are already feeling the strain. So what's the surge plan in New South Wales, and will it work the way the State Government is hoping?  Featured:  Dr Greg Fox, Professor of Respiratory Medicine at the University of Sydney, and respiratory physician, Royal Prince Alfred Hospital, Sydney

Dr. Randy Brown, MD, Global Senior Director of Respiratory Medicine for Teva Pharmaceuticals, discusses symptoms and tips for managing asthma during allergy season. He talks about the best ways to communicate asthma symptoms during a telehealth appointment, and how technology such as Teva's Digihaler® family of inhalers can help inform treatment decisions and improve communication with a healthcare professional. #Asthma #Allergy #TevaPharmaceuticals Dr. Randall Brown is global senior director of respiratory medicine for Teva Pharmaceuticals. Retiring as director of asthma & COPD programs at the University of Michigan's Center for Managing Chronic Disease, for 15 years he has maintained professorship appointments at the University's School of Public Health. Dr. Brown received BA and MD degrees from the University of Michigan, and received his Master of Public Health degree from Harvard University. He conducted a Pediatrics residency at Boston University; and, Dr. Brown graduated from clinical fellowship in Pediatric Pulmonology at Harvard Medical School working at both The Children's Hospital and Brigham and Women's Hospital in Boston.

Respiratory Medicine

Celeste Kolanko, Managing Director at Liberum IME, will be joined by Julie-Lyn Noel MD, the Director of Education and Research of the EUROSPINE, the Spine Society of Europe. In addition to being a licenced physician she brings more than a decade of international medical education experience in the non-profit environment and has been instrumental in driving CME and CPD within multiple organizations including the European Respiratory Society (ERS) and the Harmonised Education in Respiratory Medicine for European Specialists (HERMES) initiative.

Chapter 1 Hot question of the day It's @jillreports' hot question of the day: Many British Columbians are a few days into their self isolation at home. We know it can be tough, so what are you doing to pass the time?  Spring cleaning Cooking/baking  Streaming shows + movies  Other, tell us in comments You can vote on Twitter at @CKNW.  You can also call the CKNW Buzz Line at (604) 331-BUZZ (2899) and leave your vote there! Chapter 2 Our provincial government is doing a lot to fight COVID-19, is it paying off? Our provincial government has done a lot to fight the curve of COVID-19, introducing a public health emergency and state of emergency, are these measures working or do we need to go even further? Guest: Keith Baldrey, Global BC Legislature Bureau Chief Chapter 3 Why you should be practicing social distancing during the COVID-19 pandemic Today we will be speaking about the side effects of the COVID-19 pandemic. The economy and our day to day life have been impacted by the uncertainty this pandemic has created. One thing that many people have questions about is the issue of social distancing. How contagious is this virus, and what measures should we all take in our daily lives to ensure that we do not spread the coronavirus throughout our community?  Guest: Dr. Christopher Carlsten, Physician, Professor and Head of Respiratory Medicine, Department of Medicine at UBC Chapter 4 Child-care providers raise coronavirus concerns in letter to B.C. premier The B.C. Child Care Owners Association is raising concerns about the province's requirement to keep daycares open. In an open letter to Premier John Horgan, association board member Pamela Wallberg says the organization is worried about the “absolute dearth of directions from your ministries despite weeks of requesting information. Guest: Pamela Wallberg, Association Board Member, B.C. Child Care Owners Association Chapter 5 Small businesses prepare for fallout of COVID-19 How are small business owners, especially those in the services industry dealing with Covid-19? Pascal Roy is the owner of Le Marche St. George in Vancouver, a small grocery store/slash restaurant. It's often packed with people spilling onto the sidewalk out front. Owner Pascal Roy joins us to talk about how he is coping.  Guest: Pascal Roy, Owner, Le Marche St. George Chapter 6 Canadians scramble to get back home amidst the COVID-19 pandemic Tens of thousands of Canadians abroad are starting to worry about how they'll get home, as commercial flights cease in many countries with shuttered borders — and they're asking the federal government to do more to help repatriate stranded travellers. Guest: Claire Newell, Travel Best Bets President Chapter 7 How to manage your social media during COVID-19 In today's technology age, a lot of people get their information from social media, but sometimes it can feel like there is an overload of info. What's the best way to wade through everything? Guest: Wei Li, UBC Vancouver School of Economics Professor Chapter 8 City of Vancouver holds special council meeting amid COVID-19 The City of Vancouver held a special council meeting this morning to address COVID-19 concerns.  Tweet from Frances Bula: Mayor says 20 bars or restos were seen open on St. Patrick's Day, in violation of city order, and he has heard multiple stories of others since then with large gatherings inside. Guest: Melissa DeGenova, City of Vancouver Councillor Chapter 9 West Vancouver seeks volunteers as antidote to social-isolation West Vancouver is calling on its residents to help seniors dealing with social isolation Guest: Jill Lawlor, Community Wellness Manager, West Vancouver Chapter 10 BC Cancer Agency asks volunteer drivers to pause pick-ups The BC Cancer Agency has advised all volunteer drivers to park their vehicles for the foreseeable future due to COVID-19 concerns  Guest: George Garrett, Legendary CKNW Reporter, now with the Volunteer BC Cancer Drivers Society

Today we will be speaking about the side effects of the COVID-19 pandemic. The economy and our day to day life have been impacted by the uncertainty this pandemic has created. One thing that many people have questions about is the issue of social distancing. How contagious is this virus, and what measures should we all take in our daily lives to ensure that we do not spread the coronavirus throughout our community?  Guest: Dr. Christopher Carlsten, Physician, Professor and Head of Respiratory Medicine, Department of Medicine at UBC

In this episode, we talk about COPD. We talk about classifying severity and the GOLD guidelines, recognition and treatment of a COPD exacerbation and include a quick review of relevant evidence that guides our treatment of patients with COPD.